By Oracle
Publication Date: 2026-01-26 13:00:00
Oracle’s leading security platform will help Voisin improve compliance, mitigate risk and expand global service offerings for its pharmaceutical customers
AUSTIN, Texas, January 26, 2026 /PRNewswire/ — Voisin Consulting Life Sciences (VCLS), an established contract research organization (CRO) focused on unmet medical needs and rare drug clinical trials, has made the decision Oracle Argus to significantly improve its global pharmacovigilance activities. By choosing Argus, VCLS gains proven tools to enhance and deliver comprehensive end-to-end pharmacovigilance services to its diverse global clientele.
“As a contract research organization investing heavily in specialized clinical trials, providing state-of-the-art and highly efficient pharmacovigilance services is fundamental to our success and the safety of our customers’ patients,” said Dr. Emmanuelle Voisin, founder and managing director of VCLS. “Oracle Argus offers the advanced features…
